Featured Story

Who's (partly) to blame for Theranos' fallout? Silicon Valley tech reporters

A lot of fingers have been pointed during Theranos' fall from grace, with most of them directed at the company and its beleaguered front woman Elizabeth Holmes. But now, a new report is placing some of the blame on new shoulders: the Silicon Valley press.

MVM raises $233M life sciences fund

MVM Life Science Partners has closed a $233 million fourth fund to invest in technologies, therapeutics, medical devices and healthcare IT companies.

Tandem off 20% as it loses insurer to Medtronic for insulin pumps

Perhaps not too surprisingly, medical device megagiant Medtronic has again bested tiny Tandem Diabetes Care in the continuous glucose monitor market. Tandem disclosed that its customer UnitedHealthcare would adopt Medtronic as its in-network insulin pump provider.

Halyard denies mismarketing claims while law firm raises the stakes

Following allegations aired on CBS' 60 Minutes Sunday that Halyard Health for years deliberately marketed substandard healthcare equipment, the medical device and equipment company struck back on Monday with a denial.

Dexcom targets Europe as it buys distributor, opens HQ and aims for reimbursement

Dexcom is working to up its commercial game in Europe. The latest part of that plan is an acquisition of its distributor in Germany, Switzerland and Austria: Nintamed.